230
Participants
Start Date
April 20, 2020
Primary Completion Date
February 24, 2021
Study Completion Date
February 24, 2021
ARQ-252 cream 0.3%
ARQ-252 cream 0.3%
ARQ-252 cream 0.1%
ARQ-252 cream 0.1%
ARQ-252 Vehicle Cream
ARQ-252 Vehicle Cream
Arcutis Clinical Site 306, Westmead
Arcutis Clinical Site 303, East Melbourne
Arcutis Clinical Site 171, New York
Arcutis Clinical Site 135, Pittsburgh
Arcutis Clinical Site 125, Rockville
Arcutis Clinical Site 169, Norfolk
Arcutis Clinical Site 115, High Point
Arcutis Clinical Site 104, Sanford
Arcutis Clinical Site 167, Coral Gables
Arcutis Clinical Site 174, Aventura
Arcutis Clinical Site 217, Louisville
Arcutis Clinical Site 214, Indianapolis
Arcutis Clinical Site 212, Detroit
Arcutis Clinical Site 216, New Brighton
Arcutis Clinical Site 213, Metairie
Arcutis Clinical Site 164, Houston
Arcutis Clinical Site 104, College Station
Arcutis Clinical Site 161, San Antonio
Arcutis Clinical Site 110, San Antonio
Arcutis Clinical Site 163, Pflugerville
Arcutis Clinical Site 162, Austin
Arcutis Clinical Site 239, Beverly Hills
Arcutis Clinical Site 208, Santa Monica
Arcutis Clinical Site 225, Encino
Arcutis Clinical Site 120, Irvine
Arcutis Clinical Site 112, Fremont
Arcutis Clinical Site 173, Portland
Arcutis Clinical Site 207, Surrey
Arcutis Clinical Site 205, Ajax
Arcutis Clinical Site 218, Barrie
Arcutis Clinical Site 103, London
Arcutis Clinical Site 133, Mississauga
Arcutis Clinical Site 165, Oakville
Arcutis Clinical Site 109, Peterborough
Arcutis Clinical Site 241, Richmond Hill
Arcutis Clinical Site 106, Waterloo
Arcutis Clinical Site 242, Montreal
Lead Sponsor
Arcutis Biotherapeutics, Inc.
INDUSTRY